Back
Results - Announcements
Sales rise 22.82% to Rs 169.79 crore
Ind-Swift Laboratories consolidated net profit declines 93.20% in the March 2026 quarter
29-May-2026, 07:41
Net profit of Ind-Swift Laboratories declined 93.20% to Rs 15.11 crore in the quarter ended March 2026 as against Rs 222.27 crore during the previous quarter ended March 2025. Sales rose 22.82% to Rs 169.79 crore in the quarter ended March 2026 as against Rs 138.24 crore during the previous quarter ended March 2025.
Net profit of Ind-Swift Laboratories declined 93.20% to Rs 15.11 crore in the quarter ended March 2026 as against Rs 222.27 crore during the previous quarter ended March 2025. Sales rose 22.82% to Rs 169.79 crore in the quarter ended March 2026 as against Rs 138.24 crore during the previous quarter ended March 2025.
For the full year,net profit declined 83.46% to Rs 41.42 crore in the year ended March 2026 as against Rs 250.48 crore during the previous year ended March 2025. Sales rose 14.17% to Rs 641.29 crore in the year ended March 2026 as against Rs 561.71 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 169.79 | 138.24 | 23 | 641.29 | 561.71 | 14 |
| OPM % | 12.11 | -6.66 | - | 7.03 | -3.45 | - |
| PBDT | 25.22 | 22.02 | 15 | 90.66 | 59.08 | 53 |
| PBT | 17.11 | 14.58 | 17 | 60.06 | 34.60 | 74 |
| NP | 15.11 | 222.27 | -93 | 41.42 | 250.48 | -83 |
Powered by Capital Market - Live News
